Detail page

Knowledge Web

Person

Stephan Lobitz

Arzt

Name	Stephan Lobitz
Place	Koblenz (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Dr. med. MSc.
Profession	Arzt (characteristic profession) Hämatologe Onkologe
Related	Kinderkrankenhaus Amsterdamer Straße (2017-2019) Gemeinschaftsklinikum Mittelrhein (2019-)
Record type	Person
GND-Identifier	1205385932
Record ID	1205385932
Involved in show all Sichelzellkrankheit und beta-Thalassämien - rechtzeitig diagnostizieren, adäquat behandeln : Pathophysiologie, Initial- und Verlaufsdiagnostik, Therapie Antimicrobial use in pediatric oncology and hematology in Germany and Austria, 2020/2021 : a cross-sectional, multi-center point-prevalence study with a multi-step qualitative adjudication process Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol Complete Tracheal Ring Deformity, Recurrent Pneumothoraces and Pleuropulmonary Blastoma in a Child: Coincidence or Common Genetic Cause? Neugeborenenscreening auf Sichelzellkrankheit Neugeborenenscreening auf Sichelzellkrankheit in Deutschland Benefits of a disease management program for sickle cell disease in Germany 2011–2019 : the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome Benefits of a disease management program for sickle cell disease in Germany 2011–2019: the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome Introduction of universal newborn screening for sickle cell disease in Germany - a brief narrative review Sickle cell disease in Germany: results from a national registry Sickle cell disease in Germany: Results from a national registry Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Stephan Lobitz

Sichelzellkrankheit und beta-Thalassämien - rechtzeitig diagnostizieren, adäquat behandeln : Pathophysiologie, Initial- und Verlaufsdiagnostik, Therapie

Antimicrobial use in pediatric oncology and hematology in Germany and Austria, 2020/2021 : a cross-sectional, multi-center point-prevalence study with a multi-step qualitative adjudication process

Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol

Complete Tracheal Ring Deformity, Recurrent Pneumothoraces and Pleuropulmonary Blastoma in a Child: Coincidence or Common Genetic Cause?

Neugeborenenscreening auf Sichelzellkrankheit

Neugeborenenscreening auf Sichelzellkrankheit in Deutschland

Benefits of a disease management program for sickle cell disease in Germany 2011–2019 : the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome

Benefits of a disease management program for sickle cell disease in Germany 2011–2019: the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome

Introduction of universal newborn screening for sickle cell disease in Germany - a brief narrative review

Sickle cell disease in Germany: results from a national registry

Sickle cell disease in Germany: Results from a national registry

Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications

Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns